Bio Green Med Solution, Inc. — Director's Dealing 2020

Dec 15, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cyclacel Pharmaceuticals, Inc. (CYCC)
CIK: 0001130166
Period of Report: 2020-12-11

Reporting Person: McBarron Paul (Director, See Remarks)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-11	Stock Option (right to buy)	$4.32	A	120000	Acquired	2030-12-11	Common Stock (120000)	Direct

Footnotes

F1: These securities are exercisable over a three-year period, with 1/36 of the options granted vesting on a monthly basis.

F2: These securities were granted as part of the Issuer's annual compensation review to executive officers.